INTRODUCTION
============

Adenocarcinoma of the stomach is the most common malignancy in Korea^[@b1-kjim-2-2-163-6]^. Although patients with early localized disease are often curable by surgery, the majority of patients present advanced disease with metastasis which is not curable and the prognosis is very poor. Until now no form of cytotoxic chemotherapy for these advanced diseases has made a significant improvement of response rate and survival^[@b2-kjim-2-2-163-6],[@b3-kjim-2-2-163-6]^. The poor prognosis and the low response rate to chemotherapy provide considerable impetus to search for more effective forms of chemotherapy. Advances in the chemotherapy of stomach cancer appear likely to come either from the new discovery of drugs and combinations of drugs more active or from developing methods for the selection of specific forms of chemotherapy for individual patients based on the drug sensitivity of their tumors.

The human tumor stem cell clonogenic assay developed by Salmon and Hamburger^[@b4-kjim-2-2-163-6]^ provides good methods not only for *in vitro* chemosensitivity tests but for studying tumor biology. Several investigators have reported results suggesting a good correlation between *in vitro* drug sensitivity measured by clonogenic assay and the *in vitro* responsiveness^[@b5-kjim-2-2-163-6]^.

Since 1984, the authors have studied clonogenic assay of human tumor stem cell using a double agar method of Salmon and Hamburger in an attempt to applicate this assay to a variety of clinical situations^[@b6-kjim-2-2-163-6]^. In this paper, the results of clonogenic assay including morphologic study of colonies and *in vitro* chemosensitivity tests in stomach cancer are presented. This information should provide a basis for future clinical application of the clonogenic assay, especially for clinical trial designs.

MATERIALS AND METHODS
=====================

1.. Collection of Tumor Specimens
---------------------------------

In a 22-month period from October 1984 to July 1986, the authors tried *in vitro* clonogenic assay on 21 specimens from advanced stomach cancer patients. Nineteen were from malignant effusions (ascites 17, pleural effusions 2) and 2 from tumor nodules.

2.. Preparation of Tumor Single Cell Suspension
-----------------------------------------------

Malignant effusions were collected in heparinized bottles (50 μ/ml). After centrifugation at 1,500 rpm for 10 min, the cells were harvested and washed twice in McCoy's wash (McCoy's 5A Medium containing 10% heat-inactivated fetal calf serum and penicillin/streptomycin/fungizone solution). Tumor cells were collected by centrifugation over a Ficoll-Conray (specific gravity 1,080) gradient at 1,850 rpm for 45 min, then washed twice with McCoy's wash.

Tumor nodules obtained immediately after surgery were mechanically minced. They were minced with a iris scissor in McCoy's wash and then washed by centrifugation at 1,000 rpm for 5 min. Cells thus freed were separated from the tissue fragments by pouring them twice over a 120 stainless steel mesh screen. Remaining tissues were gently returned to the petri dish and the mincing procedure was repeated until cell release was no longer significant.

The viability of single cell suspension determined by a trypan blue dye exclusion method ranged from 45 to 95% (mean 83±15%).

3.. Culture Assay for Tumor Colony-Forming Cells
------------------------------------------------

The cells were cultured according to the technique of Salmon and Hamburger^[@b6-kjim-2-2-163-6],[@b7-kjim-2-2-163-6]^. Briefly, the tumor cells collected were incorporated into 0.3% agar with double enriched CMRL 1066 medium to yield a final viable cell number of 5×10^5^/ml. One ml aliquots of the agar-cell mixture (top layer) were pipetted onto 35 mm plastic petri dishes previously prepared with an under layer which contained 0.5% agar with double enriched McCoy's 5A medium.

After preparation of both the under and top layers, the dishes were examined with inverted microscope to assure the presence of a good single cell suspension and the even distribution. The dishes were incubated at 37°C in a fully humidified chamber of 7.5% CO~2~ for 2 weeks.

After incubation for 14 days, the number of colonies on the triplicate dishes was counted with an inverted microscope.

Clusters were considered aggragates of less than 30 cells. Aggregates of 30 or more cells were considered colonies. We defined cultures as positive growth when at least 5 tumor colonies grew in a dish. The plating efficiency (PE) was calculated as follows: $$\text{PE}\,(\%)\, = \,\frac{\text{Number}\,\text{of}\,\text{colony}\,\text{per}\,\text{dish}}{\text{Number}\,\text{of}\,\text{viable}\,\text{tumor}\,\text{cells}\,\text{plated}}\, \times \, 100$$

4.. In Vitro Chemosensitivity and in Vivo Correlation
-----------------------------------------------------

Stock solutions of intravenous formulations of 5-fluorouracil, adriamycin and cisplatin were prepared in sterile buffered saline and stored at −70°C in aliquots sufficient for individual assays. Subsequent dilutions were made in medium for cell incubation. Tumor cell suspensions were transferred to tubes and adjusted to a final number of 5×10^5^ cells/ml in the presence of the appropriate drug dilution or a control medium. Each drug was tested at a minimum of three dose levels, including pharmacologically achievable concentrations. Cells were incubated with drugs in McCoy's medium for one hour at 37°C.

The cells were then centrifuged at 1,500 rpm for 5 min, washed twice in medium, and prepared for culture. The number of colonies on control plates and drug-treated plates was counted. At least 30 tumor colonies per plate were required in the control plates to assure an adequate range for measurement of drug effect. We defined drug sensitivity of a given tumor as a more than 50% reduction of colony formation (less than 50% survival) in the presence of the drug compared to colony formation in the absence of the drug. Four patients with malignant ascites were treated with cisplatin intraperitoneally^[@b8-kjim-2-2-163-6]^. *In vivo* response was defined as clearing of the effusion without reaccumulation of fluid accompanied with disappearance of tumor cells in ascitic fluid.

5.. Morphologic Studies of Tumor Colonies
-----------------------------------------

Serial examination with an inverted microscope was performed to observe the process of cell division and colony formation. After 14 days, we fixed wet agar cultures with a 3% solution of glutaraldehyde in Hank's balanced salt solution and placed them in a humidified plastic box and stored in the cold room for the morphologic study.

Permanent dry slides were prepared from top plating layer separated^[@b9-kjim-2-2-163-6]^. The plating layer then was poured gently onto a microscope slide and a prewetted cellulose acetate membrane was carefully placed on top of the wet agar. Once the slide dried, the cellulose acetate strip was removed. The dried slide was stained with Papanicolaou method.

RESULTS
=======

1.  The overall growth rate was 71.4% (15 of 21). The growth rates of tumor cells obtained from ascites, pleural effusions and tumor nodules were 70.5% (12 of 17), 100% (2) and 50% (1 of 2) respectively ([Table 1](#t1-kjim-2-2-163-6){ref-type="table"}, [2](#t2-kjim-2-2-163-6){ref-type="table"}).

2.  The number of the colonies ranged from 5 to 96 per petri dish, and the median was 20. The PE ranged from 0.001 to 0.036%, and the median was 0.003% ([Table 1](#t1-kjim-2-2-163-6){ref-type="table"}, [2](#t2-kjim-2-2-163-6){ref-type="table"}).

3.  The *in vitro* chemosensitivity tests were performed in 5 patients, and the result showed 4 sensitive and 1 resistant to cisplatin ([Table 3](#t3-kjim-2-2-163-6){ref-type="table"}). In 3 cases sensitive to cisplatin, dose-related responses were seen ([Fig. 1](#f1-kjim-2-2-163-6){ref-type="fig"}). The result of trial with intraperitoneal instillation of cisplatin revealed that 3 patients *in vitro* sensitive were responsive *in vivo*, and 1 patient *in vitro* resistant was non-responsive *in vivo*.

4.  In morphologic studies, the colonies made of tightly packed cells were grown from the pooly differentiated adenocarcinoma whereas the colonies made of loosely packed cells with mucin formation were grown from the mucin secreting adenocarcinoma ([Fig. 2](#f2-kjim-2-2-163-6){ref-type="fig"}).

DISCUSSION
==========

This study has shown that gastric adenocarcinoma can be grown successfully in a human tumor clonogenic assay using a double agar method. The overall growth rate was 71.4% including 14 of 19 (73.7%) malignant effusions and 1 of 2 tumor specimens. This data is similar to the previously published results by several investigators. Von Hoff et al.^[@b5-kjim-2-2-163-6],[@b10-kjim-2-2-163-6]^ reported the growth rate as 70% in a rather large variety of tumor types and noted that the solid tumor and lymph node specimens were more difficult to grow than malignant effusions because of technical problems in maintaining viability while making single cell suspensions.

The median number of colonies formed from stomach cancer specimens was 20 (ranged from 5 to 96) and the PE was 0.001 ∼ 0.036% (median 0.003%). Von Hoff et al.^[@b10-kjim-2-2-163-6]^ showed the PE in neuroblastoma, ovarian cancer, breast cancer, melanoma and colorectal cancer as 0.01%, 0.01%, 0.01%, 0.006% and 0.005% respectively. Laboisse et al.^[@b11-kjim-2-2-163-6]^ reported the PE in stomach cancer as ranged from 0.006 to 0.82%. Therefore, the PE varied considerably both in terms of median PE from different tumor type and in terms of range of PE within a same tumor type. Also, approximately 70% of all tumors plated in the stem cell assay exhibit colony formation, but in over one half of the cases, cloning efficiency is too low to permit further detailed studies^[@b12-kjim-2-2-163-6]^. The low PE may reflect not only a small cell population in a tumor and a large number of non-tumor cells in the inoculum but also an inherent feature of spontaneous human tumor. It is believed that less than 0.1% of tumor cells are usually clonogenic. The variation within a type of tumor could reflect differences in stage of tumor, time since prior treatment, site of tumor sampled, type of specimens sampled and method preparing tumor specimens. The PE will likely be improved somewhat with better techniques for cell disaggregation, adjustment in medium components, and/or addition of appropriate growth factors and hormones. Increasing the number of nucleated cells per plate did not usually increase the number of colonies^[@b10-kjim-2-2-163-6]^.

The authors experienced that it is not easy to obtain sterile single cell suspensions from stomach cancer tissue enough to study clonogenic assay. Because the tumor specimens were usually contaminated and frequently too necrotic to get enough cells. The viability of cells from tumor specimens was lower than from malignant effusions. Also in the case of mucinous adenocarcinoma, it is very diffcult to disaggregate mechanically due to the presence of mucin (data not shown). The method of clonogenic assay in stomach cancer will be improved with enzymatic disaggregation and careful decontamination.

Patterns of chemosensitivity obtained for 5 cases are shown in [Table 3](#t3-kjim-2-2-163-6){ref-type="table"}. All but one patient (case No. 8) had prior chemotherapy (5-fluorouracil, adriamycin and mitomycin). Using the authors' criterion, 4 of 5 tumors were sensitive *in vivo* to cisplatin and one was resistant. For the *in vivo* study, 4 patients received cisplatin intraperitoneally to control malignant ascites. The results of *in vivo* and *in vitro* study showed that 3 patients responsive to intraperitoneal cisplatin were sensitive to cisplatin *in vitro*. Whereas, 1 patient non-responsive to intraperitoneal cisplatin was resistant to cisplatin *in vitro*. Generally speaking, the *in vitro* chemosensitivity tests using clonogenic assay is more valuable in predicting which drugs would not be useful clinically (*in vitro* resistant and *in vivo* non-responsive) than in predicting which drugs would be useful clinically (*in vitro* sensitive and *in vivo* responsive)^[@b13-kjim-2-2-163-6],[@b14-kjim-2-2-163-6]^. Overall, the true negative rate is about 90% while true positive rate is ranged from 60 to 70%.

Cultures were examined with an inverted microscope to observe the process of cell division and colony formation. In general, 2 cells, 4 cells and 8 cells stage were observed on the 3rd, 6th and 7th day after plating respectively. Clusters appeared on the 8th day and colonies began to appear from the 10th day after plating. Colonies consisted of 30 to several hundred large round cells (data not shown). We prepared permanent slide stained with Papanicolaou method from a wet agar for the morphologic study. The morphology of human stomach cancer colonies was similar to stomach cancer as identified in the original specimens ([Fig. 2](#f2-kjim-2-2-163-6){ref-type="fig"}).

In this study, the authors could grow colonies from stomach cancer tissues and observed good correlation between *in vitro* chemosensitivity tests and *in vivo* results. However, the PE was low and the number of colonies was not enough to determine the chemosensitivity in all patients. By improving the assay techniques, we could applicate this clonogenic assay to a variety of clinical research including further chemosensitivity test, morphologic study with electron microscope and chromosomal analysis.
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![In vitro chemosensitivity of case No. 2 and No. 5 to cisplatin (●) and case No. 9 to 5-fluorouracil (○).](kjim-2-2-163-6f1){#f1-kjim-2-2-163-6}

![A. Poorly differentiated adenocarcinoma.\
a. Original histology, HE stain ×400.\
b. Colony characterized by numerous tightly packed cells ×400.\
c. Papanicolaou stain of colony after permanent fixation ×400.\
B. Mucin secreting adenocarcinoma.\
a. Original histology, HE stain ×400.\
b. Colony made of loosly packed cells with mucin formation ×200.\
c. Papanicolaou stain of the colony ×400.](kjim-2-2-163-6f2){#f2-kjim-2-2-163-6}

###### 

Characteristics of Patients with Stomach Cancer and Colony Formation in a Double Agar System

  Case No.                                                      Age/Sex   Histology^[\*](#tfn1-kjim-2-2-163-6){ref-type="table-fn"}^   Specimen           Viability (%)   No. of colony   Plating efficiency (%)
  ------------------------------------------------------------- --------- ------------------------------------------------------------ ------------------ --------------- --------------- ------------------------
  1                                                             43/M      AWD                                                          Ascites            95              5               0.001
  2                                                             66/M      AWD                                                          Ascites            95              45 ± 9          0.010
  3                                                             70/M      AMUCIN                                                       Ascites            53              96 ± 20         0.036
  4                                                             50/M      AMD                                                          Ascites            93              5               0.001
  5                                                             54/M      APD                                                          Ascites            95              59 ± 20         0.012
  6                                                             63/M      APD                                                          Ascites            83              16 + 4          0.003
  7                                                             40/F      APD                                                          Ascites            80              5               0.001
  8                                                             35/F      APD                                                          Ascites            79              47 ± 12         0.012
  9                                                             56/F      APD                                                          Ascites            87              38 ± 9          0.009
  10                                                            62/F      APD                                                          Ascites            95              10              0.002
  11                                                            49/M      AWD                                                          Ascites            95              23 ± 22         0.005
  12                                                            59/F      APD                                                          Ascites            80              7               0.001
  13                                                            29/F      AMD                                                          Ascites            70              0               0\.
  14                                                            74/M      APD                                                          Ascites            95              0               0\.
  15                                                            59/F      APD                                                          Ascites            75              0               0\.
  16                                                            70/M      APD                                                          Ascites            89              0               0\.
  17                                                            43/M      APD                                                          Ascites            88              0               0\.
  18                                                            40/F      APD                                                          Pleural effusion   80              5               0.001
  19                                                            23/M      APD                                                          Pleural effusion   90              6 ± 3           0.001
  20                                                            66/M      APD                                                          Mass               45              33 ± 7          0.007
  21                                                            70/F      APD                                                          Mass               83              0               0\.
                                                                                                                                                                                          
  Mean viability : 83.0 ± 15.3%                                                                                                                                                           
  Median No. of colony/dish (range) : 20 (5 -- 96)                                                                                                                                        
  Median plating efficiency (range) : 0.003% (0.001 -- 0.036)                                                                                                                             

AWD  : Adenocarcinoma, well differentiated

AMD  : Adenocarcinoma, moderately differentiated

APD  : Adenocarcinoma, poorly differentiated

AMUCIN  : Mucin secreting adenocarcinoma

###### 

Growth of Tumor Cells by Source of Specimen

  Specimen           Growth rate
  ------------------ ---------------
  Ascites            12/17 (70.5%)
  Pleural effusion   2/2 (100.0%)
  Tumor nodule       1/2 (50.0%)
                     
  Total              15/21 (71.4%)

###### 

Correlation of *in vitro* and *in vivo* Sensitivity of Stomach Cancer to Chemotherapy

  Case No.   Previous chemotherapy   *In vitro^[\*](#tfn5-kjim-2-2-163-6){ref-type="table-fn"}^*   *In vivo^[\*](#tfn5-kjim-2-2-163-6){ref-type="table-fn"}^*       
  ---------- ----------------------- ------------------------------------------------------------- ------------------------------------------------------------ --- ----
  2          FAM                     S                                                             S                                                            S   S
  3          FAM                     ND                                                            ND                                                           R   R
  5          FAM                     ND                                                            ND                                                           S   S
  8          None                    ND                                                            ND                                                           S   S
  9          FAM                     S                                                             ND                                                           S   ND

R : Resistant,

S : Sensitive,

ND : Not done
